•
BV
BVS
Bioventus Inc. Class A Common Stock
yahooSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
535.81M
Volume
242.69K
52W High
$11.25
52W Low
$5.81
Open
$0.00
Prev Close
$7.71
Day Range
0.00 - 0.00
About Bioventus Inc. Class A Common Stock
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Latest News
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
GlobeNewswire Inc.•Aug 4
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights
GlobeNewswire Inc.•Apr 10
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034
GlobeNewswire Inc.•Nov 26
U.S. Osteoarthritis Injectables Market Analysis 2024-2030: Rising Prevalence of Osteoarthritis & Increase in R&D Activities for Injectable Drug Developments Spurs Growth
GlobeNewswire Inc.•Oct 4
First September Gains in 5 Years? Buy 3 Breakout Stocks Now
Benzinga•Sep 24
Pseudarthrosis Treatment Market is Projected to Reach $1.37 Billion at a CAGR 4.6% by 2034 | Fact.MR Report
GlobeNewswire Inc.•Sep 5
Corcept Shares Rise More Than 45% in Six Months: Here's Why
Benzinga•Sep 3
U.S. Autoimmune Disease Diagnostics (Systemic, Localized) Market Size, Share & Trends Analysis Report 2024-2030 - GlobeNewswire
GlobeNewswire Inc.•Jul 11